Feasibility of Mass Vaccination Campaign with Oral Cholera Vaccines in Response to an Outbreak in Guinea

PLoS Medicine

Volumn 10, Issue 9, 2013, Pages

  Ciglenecki, Iza ^a   Sakoba, Keita ^b   Luquero, Francisco J ^c   Heile, Melat ^a   Itama, Christian ^d   Mengel, Martin ^e   Grais, Rebecca F ^c   Verhoustraeten, Francois ^a   Legros, Dominique ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Ministry of Health   (Guinea)

^c EPICENTRE   (France)

^d World Health Organisation ^*  (Guinea)

^e African Cholera Surveillance Network   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE;

ARTICLE; EPIDEMIC; GUINEA; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; MASS IMMUNIZATION; PATIENT CARE; PUBLIC HEALTH; SANITATION; TEAM NURSING; THERMOSTABILITY;

ADMINISTRATION, ORAL; CHOLERA; CHOLERA VACCINES; DISEASE OUTBREAKS; FEASIBILITY STUDIES; GUINEA; HEALTH CARE COSTS; HUMANS; MASS VACCINATION;

EID: 84884663062     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001512     Document Type: Article

References (17)

1. World Health Organization (2011) Cholera, 2010. Wkly Epidemiologic Rec 31: 325-338 Available: http://www.who.int/wer/2011/wer8631.pdf. Accessed 4 July 2013.
2. United Nations Children's Fund and World Health Organization, 2012. Progress on drinking water and sanitation, 2012 update. Available: http://www.unicef.org/media/files/JMPreport2012.pdf. Accessed 5 March 2013.
3. Barzilay EJ, Schaad N, Magloire R, Mung KS, Boncy J, et al. (2013) Cholera surveillance during the Haiti epidemic - the first 2 years. N Engl J Med 368: 599-609 DOI: 10.1056/NEJMoa1204927.
4. World Health Organization (2010) Cholera vaccines WHO position paper. Wkly Epidemiologic Rec 13: 117-128 Available: http://www.who.int/wer/2010/wer8513.pdf. Accessed 5 March 2013.
5. Sur D, Kanungo S, Sah B, Manna B, Ali M, et al. (2011) Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis 5 (10) (): e1289 doi:10.1371/journal.pntd.0001289.
6. Date K, Hyde T, Mintz E, Vicari A, Danovaro-Holliday MC, et al. (2011) Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011. Emerg Infect Dis 17: 2105-12 doi:10.3201/eid1711.110822.
7. Cumberland S, (2009) An old enemy returns. Bull World Health Org 87: 85-6 Doi:10.2471/BLT.09.010209.
8. Anh DD, Lopez AL, Thiem VD, Grahek SL, Duong TN, et al. (2011) Use of oral cholera vaccines in an outbreak in Vietnam: A case control study. PLoS Negl Trop Dis 5: e1006 doi:10.1371/journal.pntd.0001006.
9. Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary M, et al. (2004) Can oral cholera vaccination play a role in controlling a cholera outbreak? Vaccine 22: 2444-51.
10. De Brettes A, de Carsalade GY, Petinelli F, Benoit Cattin T, Coulaud X, et al. (2001) Le cholera à Mayotte. Bulletin Epidémiologique Hebdomadaire 8: 33-35.
11. Beatty ME, Jack T, Sivapalasingam S, Yao SS, Paul I, et al. (2004) An Outbreak of Vibrio cholerae O1 infections on Ebeye Island, Republic of the Marshall Islands, associated with use of an adequately chlorinated water source. Clin Inf Dis 38: 1-9.
12. World Health Organisation (2013) Cholera country profile: Guinea. Available: http://www.who.int/cholera/countries/CountryProfileGuinea2009.pdf Accessed 5 March 2013.
13. World Health Organization (2012) Outbreak bulletin 2:2. Available: http://www.afro.who.int/en/clusters-a-programmes/dpc/epidemic-a-pandemic-alert-and-response/outbreak-news/3690-cholera-in-sierra-leone-update-18-september-2012.html. Accessed 5 March 2013.
14. Kanungo S, Paisley A, Lopez AL, Bhattacharya M, Manna B, et al. (2009) Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial. Vaccine 27: 6887-93.
15. Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, et al. (2005) Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 366: 44-49 doi:10.1016/S0140-6736(05)66550-6.
16. Khatib AM, Ali M, Seidlein L, Kim DR, Hashim R, et al. (2012) Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis 12: 837-844 doi:10.1016/S1473-3099(12)70196-2.
17. Martin S, Costa A, Perea W, (2012) Stockpiling oral cholera vaccine. Bull World Health Organ 90: 714 doi: 10.2471/BLT.12.112433.